These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2555213)

  • 1. Effects of recombinant tumor necrosis factor (rHuTNF alpha) on human neutrophils and monocytes: in vitro, ex vivo and in vivo.
    Schell-Frederick E; Tepass T; Lorscheidt G; Pfreundschuh M; Schaadt M; Diehl V
    Eur J Haematol; 1989 Oct; 43(4):286-96. PubMed ID: 2555213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human tumor necrosis factor alpha lacks chemotactic activity for human peripheral blood neutrophils and monocytes.
    Mrowietz U; Schröder JM; Christophers E
    Biochem Biophys Res Commun; 1988 Jun; 153(3):1223-8. PubMed ID: 3390181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of human neutrophil and monocyte chemotaxis and superoxide responses by recombinant TNF-alpha and GM-CSF.
    Kharazmi A; Nielsen H; Bendtzen K
    Immunobiology; 1988 Sep; 177(4-5):363-70. PubMed ID: 2848761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-alpha and -beta: comparison to recombinant interferon-gamma and interleukin-1 alpha.
    Figari IS; Mori NA; Palladino MA
    Blood; 1987 Oct; 70(4):979-84. PubMed ID: 2820532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline differentially regulates migration and respiratory burst activity of the neutrophil.
    Dunzendorfer S; Schratzberger P; Reinisch N; Kähler CM; Wiedermann CJ
    Ann N Y Acad Sci; 1997 Dec; 832():330-40. PubMed ID: 9704061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of neutrophil migration by tumor necrosis factor. Ex vivo and in vivo studies in comparison with in vitro effect.
    Otsuka Y; Nagano K; Nagano K; Hori K; Oh-ishi J; Hayashi H; Watanabe N; Niitsu Y
    J Immunol; 1990 Oct; 145(8):2639-43. PubMed ID: 2170522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming and stimulation of bovine neutrophils by recombinant human interleukin-1 alpha and tumor necrosis factor alpha.
    Sample AK; Czuprynski CJ
    J Leukoc Biol; 1991 Feb; 49(2):107-15. PubMed ID: 1846902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human tumour necrosis factor beta (lymphotoxin) lacks chemotactic activity for human peripheral blood neutrophils, monocytes, and T cells.
    Mrowietz U; Ternowitz T; Schröder JM; Christophers E
    Scand J Immunol; 1989 Sep; 30(3):373-7. PubMed ID: 2789431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma.
    Issekutz AC; Issekutz TB
    J Immunol; 1993 Aug; 151(4):2105-15. PubMed ID: 8345197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redundant function of macrophage inflammatory protein-2 and KC in tumor necrosis factor-alpha-induced extravasation of neutrophils in vivo.
    Zhang XW; Wang Y; Liu Q; Thorlacius H
    Eur J Pharmacol; 2001 Sep; 427(3):277-83. PubMed ID: 11567658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor alpha induces migration of human eosinophils.
    Nagata M; Fukuda T; Numao T; Makino S; Dohi Y
    Arerugi; 1993 Apr; 42(4):549-55. PubMed ID: 8323453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor infusions in humans prime neutrophils for hypochlorous acid production.
    Wewers MD; Rinehart JJ; She ZW; Herzyk DJ; Hummel MM; Kinney PA; Davis WB
    Am J Physiol; 1990 Oct; 259(4 Pt 1):L276-82. PubMed ID: 2171355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha decreases neutrophil chemotaxis to N-formyl-1-methionyl-1-leucyl-1-phenylalanine: analysis of single cell movement.
    Vollmer KL; Alberts JS; Carper HT; Mandell GL
    J Leukoc Biol; 1992 Dec; 52(6):630-6. PubMed ID: 1464735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological effects of recombinant human GM-CSF.
    Shadduck RK; Kaplan SS; Whiteside TL; Wing EJ
    Prog Clin Biol Res; 1990; 352():365-74. PubMed ID: 2169633
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of tumor necrosis factor-alpha on the stimulus-coupled responses of neutrophils and their modulation by various inhibitors.
    Utsumi T; Klostergaard J; Akimaru K; Sato EF; Yoshioka T; Utsumi K
    Physiol Chem Phys Med NMR; 1992; 24(2):77-88. PubMed ID: 1324505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
    Harvath L; Aksamit RR
    J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming of neutrophils by lipopolysaccharide for enhanced release of superoxide. Requirement for plasma but not for tumor necrosis factor-alpha.
    Aida Y; Pabst MJ
    J Immunol; 1990 Nov; 145(9):3017-25. PubMed ID: 2170529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression.
    Groves RW; Allen MH; Ross EL; Barker JN; MacDonald DM
    Br J Dermatol; 1995 Mar; 132(3):345-52. PubMed ID: 7536438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protein kinase C inhibitor AEB071 (sotrastaurin) modulates migration and superoxide anion production by human neutrophils in vitro.
    Capsoni F; Ongari AM; Reali E; Bosè F; Altomare GF
    Int J Immunopathol Pharmacol; 2012; 25(3):617-26. PubMed ID: 23058012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of human neutrophilic granulocyte functions by recombinant human tumor necrosis factor and recombinant human lymphotoxin. Promotion of adherence, inhibition of chemotactic migration and superoxide anion release from adherent cells.
    Kownatzki E; Kapp A; Uhrich S
    Clin Exp Immunol; 1988 Oct; 74(1):143-8. PubMed ID: 2851397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.